These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 25923171

  • 21. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
    Zhou QT, Sun SP, Chan JG, Wang P, Barraud N, Rice SA, Wang J, Li J, Chan HK.
    Mol Pharm; 2015 Aug 03; 12(8):2594-603. PubMed ID: 25423590
    [Abstract] [Full Text] [Related]

  • 22. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.
    Akdag Cayli Y, Sahin S, Buttini F, Balducci AG, Montanari S, Vural I, Oner L.
    Drug Dev Ind Pharm; 2017 Aug 03; 43(8):1378-1389. PubMed ID: 28420285
    [Abstract] [Full Text] [Related]

  • 23. Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation.
    Mangal S, Nie H, Xu R, Guo R, Cavallaro A, Zemlyanov D, Zhou QT.
    Pharm Res; 2018 Jan 08; 35(2):28. PubMed ID: 29374368
    [Abstract] [Full Text] [Related]

  • 24. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
    Yu J, Romeo MC, Cavallaro AA, Chan HK.
    Int J Pharm; 2018 Apr 25; 541(1-2):11-18. PubMed ID: 29454904
    [Abstract] [Full Text] [Related]

  • 25. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI, Vinjamuri BP, Mahmoud AA, Shamma RN, Mansour SM, Ammar HO, Ghorab MM, Chougule MB, Chablani L.
    J Control Release; 2019 May 28; 302():126-139. PubMed ID: 30940497
    [Abstract] [Full Text] [Related]

  • 26. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.
    Li X, Mansour HM.
    AAPS PharmSciTech; 2011 Dec 28; 12(4):1420-30. PubMed ID: 22038473
    [Abstract] [Full Text] [Related]

  • 27. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery.
    Gomez AI, Acosta MF, Muralidharan P, Yuan JX, Black SM, Hayes D, Mansour HM.
    Pulm Pharmacol Ther; 2020 Oct 28; 64():101975. PubMed ID: 33137515
    [Abstract] [Full Text] [Related]

  • 28. Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections.
    Dimer F, de Souza Carvalho-Wodarz C, Haupenthal J, Hartmann R, Lehr CM.
    Pharm Res; 2015 Dec 28; 32(12):3850-61. PubMed ID: 26113237
    [Abstract] [Full Text] [Related]

  • 29. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
    Wu X, Hayes D, Zwischenberger JB, Kuhn RJ, Mansour HM.
    Drug Des Devel Ther; 2013 Dec 28; 7():59-72. PubMed ID: 23403805
    [Abstract] [Full Text] [Related]

  • 30. Edge activators and a polycationic polymer enhance the formulation of porous voriconazole nanoagglomerate for the use as a dry powder inhaler.
    Salem HF, Kharshoum RM, Abdel Hakim LF, Abdelrahim ME.
    J Liposome Res; 2016 Dec 28; 26(4):324-35. PubMed ID: 26872552
    [Abstract] [Full Text] [Related]

  • 31. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.
    Zhou QT, Morton DA, Yu HH, Jacob J, Wang J, Li J, Chan HK.
    J Pharm Sci; 2013 Oct 28; 102(10):3736-47. PubMed ID: 23904207
    [Abstract] [Full Text] [Related]

  • 32. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
    Zhu B, Young PM, Ong HX, Crapper J, Flodin C, Qiao EL, Phillips G, Traini D.
    J Pharm Sci; 2015 Jul 28; 104(7):2169-76. PubMed ID: 25931324
    [Abstract] [Full Text] [Related]

  • 33. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.
    Wu X, Zhang W, Hayes D, Mansour HM.
    Int J Nanomedicine; 2013 Jul 28; 8():1269-83. PubMed ID: 23569375
    [Abstract] [Full Text] [Related]

  • 34. Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations.
    Shetty N, Zeng L, Mangal S, Nie H, Rowles MR, Guo R, Han Y, Park JH, Zhou QT.
    Pharm Res; 2018 Jan 02; 35(1):7. PubMed ID: 29294198
    [Abstract] [Full Text] [Related]

  • 35. Preparation and Characterization of Inhalable Ivermectin Powders as a Potential COVID-19 Therapy.
    Albariqi AH, Ke WR, Khanal D, Kalfas S, Tang P, Britton WJ, Drago J, Chan HK.
    J Aerosol Med Pulm Drug Deliv; 2022 Oct 02; 35(5):239-251. PubMed ID: 35275749
    [Abstract] [Full Text] [Related]

  • 36. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy.
    Acosta MF, Muralidharan P, Grijalva CL, Abrahamson MD, Hayes D, Fineman JR, Black SM, Mansour HM.
    Ther Adv Respir Dis; 2021 Oct 02; 15():1753466621998245. PubMed ID: 33719747
    [No Abstract] [Full Text] [Related]

  • 37. Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist.
    Muralidharan P, Jones B, Allaway G, Biswal SS, Mansour HM.
    Sci Rep; 2020 Nov 13; 10(1):19771. PubMed ID: 33188247
    [Abstract] [Full Text] [Related]

  • 38. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA, Anderson KW, Zach Hilt J, McGarry RC, Mansour HM.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):699-711. PubMed ID: 23707466
    [Abstract] [Full Text] [Related]

  • 39. Spray dried inhalable ivacaftor co-amorphous microparticle formulations with leucine achieved enhanced in vitro dissolution and superior aerosol performance.
    Guan J, Yuan H, Yu S, Mao S, Tony Zhou Q.
    Int J Pharm; 2022 Jun 25; 622():121859. PubMed ID: 35643348
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.